Zhejiang Jolly Pharmaceutical Co.,LTD

XSEC:300181 주식 보고서

시가총액: CN¥10.9b

Zhejiang Jolly PharmaceuticalLTD 대차 대조표 상태

재무 상태 기준 확인 6/6

Zhejiang Jolly PharmaceuticalLTD has a total shareholder equity of CN¥2.6B and total debt of CN¥381.6M, which brings its debt-to-equity ratio to 14.4%. Its total assets and total liabilities are CN¥3.9B and CN¥1.2B respectively. Zhejiang Jolly PharmaceuticalLTD's EBIT is CN¥592.6M making its interest coverage ratio -58.9. It has cash and short-term investments of CN¥786.3M.

주요 정보

14.4%

부채 비율

CN¥381.56m

부채

이자 보상 비율-58.9x
현금CN¥786.31m
주식CN¥2.64b
총 부채CN¥1.23b
총 자산CN¥3.87b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

재무 상태 분석

단기부채: 300181's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥1.2B).

장기 부채: 300181's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥57.1M).


부채 대 자본 내역 및 분석

부채 수준: 300181 has more cash than its total debt.

부채 감소: 300181's debt to equity ratio has reduced from 27.8% to 14.4% over the past 5 years.

부채 범위: 300181's debt is well covered by operating cash flow (73%).

이자 보장: 300181 earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기